1-34761406-TTGTC-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_153212.3(GJB4):βc.155_158delβ(p.Val52AlafsTer55) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0413 in 1,609,388 control chromosomes in the GnomAD database, including 1,553 homozygotes. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.030 ( 94 hom., cov: 32)
Exomes π: 0.042 ( 1459 hom. )
Consequence
GJB4
NM_153212.3 frameshift
NM_153212.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.00900
Genes affected
GJB4 (HGNC:4286): (gap junction protein beta 4) This gene encodes a transmembrane connexin protein that is a component of gap junctions. Mutations in this gene have been associated with erythrokeratodermia variabilis, progressive symmetric erythrokeratoderma and hearing impairment. [provided by RefSeq, Dec 2009]
SMIM12 (HGNC:25154): (small integral membrane protein 12) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-34761406-TTGTC-T is Benign according to our data. Variant chr1-34761406-TTGTC-T is described in ClinVar as [Benign]. Clinvar id is 1276227.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0304 (4481/147534) while in subpopulation NFE AF= 0.0454 (3087/67988). AF 95% confidence interval is 0.0441. There are 94 homozygotes in gnomad4. There are 2168 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4481 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GJB4 | NM_153212.3 | c.155_158del | p.Val52AlafsTer55 | frameshift_variant | 2/2 | ENST00000339480.3 | |
GJB4 | XM_011540679.3 | c.155_158del | p.Val52AlafsTer55 | frameshift_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GJB4 | ENST00000339480.3 | c.155_158del | p.Val52AlafsTer55 | frameshift_variant | 2/2 | 2 | NM_153212.3 | P1 | |
SMIM12 | ENST00000426886.1 | c.208-43001_208-42998del | intron_variant, NMD_transcript_variant | 1 | |||||
ENST00000542839.1 | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0304 AC: 4483AN: 147424Hom.: 95 Cov.: 32
GnomAD3 genomes
AF:
AC:
4483
AN:
147424
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0327 AC: 8149AN: 249250Hom.: 171 AF XY: 0.0337 AC XY: 4553AN XY: 135008
GnomAD3 exomes
AF:
AC:
8149
AN:
249250
Hom.:
AF XY:
AC XY:
4553
AN XY:
135008
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0423 AC: 61909AN: 1461854Hom.: 1459 AF XY: 0.0421 AC XY: 30628AN XY: 727226
GnomAD4 exome
AF:
AC:
61909
AN:
1461854
Hom.:
AF XY:
AC XY:
30628
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0304 AC: 4481AN: 147534Hom.: 94 Cov.: 32 AF XY: 0.0300 AC XY: 2168AN XY: 72170
GnomAD4 genome
AF:
AC:
4481
AN:
147534
Hom.:
Cov.:
32
AF XY:
AC XY:
2168
AN XY:
72170
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3468
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 18, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at